The Predictive Value of MAP2K1/2 Mutations on Efficiency of Immunotherapy in Melanoma
BackgroundMAP2K1/2 genes are mutated in approximately 8% of melanoma patients; however, the impact of MAP2K1/2 gene alterations on the efficiency of immunotherapy has not been clarified. This study focused on the correlation between MAP2K1/2 gene mutations and the treatment response.MethodsSix metas...
Main Authors: | Ting Ye, Jie-Ying Zhang, Xin-Yi Liu, Yu-Han Zhou, Si-Yue Yuan, Meng-Mei Yang, Wen-Zhuan Xie, Chan Gao, Yao-Xu Chen, Meng-Li Huang, Cheng-Zhi Ye, Jing Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.785526/full |
Similar Items
-
Comparative efficacy and safety of combination therapies for advanced melanoma: a network meta-analysis
by: Qing An, et al.
Published: (2019-01-01) -
The age of enlightenment in melanoma immunotherapy
by: Mark R. Albertini
Published: (2018-08-01) -
Immunotherapy in non-small cell lung cancer: Past, present, and future directions
by: Salman R. Punekar, et al.
Published: (2022-08-01) -
Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress
by: Zin W. Myint, et al.
Published: (2017-04-01) -
Efficacy and Safety of Immune Checkpoint Blockades in the Treatment of Ocular Melanoma: A Systematic Review and Meta-Analysis
by: Lu Zhao, et al.
Published: (2021-12-01)